Journal
MATERIALS
Volume 14, Issue 1, Pages -Publisher
MDPI
DOI: 10.3390/ma14010004
Keywords
gold nanoparticles (AuNPs); nuclear imaging; radionuclide therapy; nanomedicine; nanotechnology
Categories
Funding
- Fundacao para a Ciencia e Tecnologia [PTDC/MED-QUI/29649/2017]
- Fundação para a Ciência e a Tecnologia [PTDC/MED-QUI/29649/2017] Funding Source: FCT
Ask authors/readers for more resources
Nanotechnology has provided novel methodologies and tools in medical oncology, particularly the use of gold nanoparticles in radiopharmaceutical development, offering nanometric platforms for nuclear imaging and/or radionuclide therapy. Numerous studies have shown the potential and significance of gold nanoparticles in cancer treatment.
In the Last decades, nanotechnology has provided novel and alternative methodologies and tools in the field of medical oncology, in order to tackle the issues regarding the control and treatment of cancer in modern society. In particular, the use of gold nanoparticles (AuNPs) in radiopharmaceutical development has provided various nanometric platforms for the delivery of medically relevant radioisotopes for SPECT/PET diagnosis and/or radionuclide therapy. In this review, we intend to provide insight on the methodologies used to obtain and characterize radiolabeled AuNPs while reporting relevant examples of AuNPs developed during the last decade for applications in nuclear imaging and/or radionuclide therapy, and highlighting the most significant preclinical studies and results.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available